Physicians' attitudes toward pharmacogenetic testing before and after pharmacogenetic education

Personalized Medicine
Jasmine A Luzum, Matthew J Luzum

Abstract

Our aim was to evaluate physicians' attitudes toward pharmacogenetic testing before and after pharmacogenetic education. In total, 12 physicians (˜40% response rate) completed a survey with eight questions on 10-point scales on their attitudes toward pharmacogenetic testing before and after a 1-h grand rounds presentation on pharmacogenetics. Differences in question scores overall, among training levels (resident/fellow/attending), and specific drugs (clopidogrel/simvastatin/warfarin) were assessed using Wilcoxon signed-rank and exact Kruskal-Wallis tests. The scores for all eight questions increased, with statistically significant (p < 0.05) increases for four out of eight questions. The scores were similar among training levels, but the postscores for clopidogrel were significantly higher than for simvastatin and warfarin. In conclusion, brief pharmacogenetic education can significantly affect physicians' attitudes toward pharmacogenetic testing.

References

Oct 26, 2000·American Journal of Medical Genetics·E Mountcastle-Shah, N A Holtzman
Dec 26, 2001·Nucleic Acids Research·Micheal HewettTeri E Klein
Nov 14, 2003·Journal of Managed Care Pharmacy : JMCP·Woodie M Zachry, Edward P Armstrong
Dec 16, 2005·Pharmacogenomics·Anja RogauschWolfgang Himmel
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V Relling, T E Klein
Feb 18, 2011·Clinical Pharmacology and Therapeutics·R B Altman
Jun 10, 2011·American Journal of Pharmaceutical Education·Kristen B McCulloughWayne T Nicholson
Sep 9, 2011·Clinical Pharmacology and Therapeutics·J A JohnsonUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jan 27, 2012·Clinical Pharmacology and Therapeutics·E J StanekF W Frueh
Apr 3, 2012·Journal of Cardiac Failure·Jasmine A TalamehJ Herbert Patterson
Mar 6, 2013·American Journal of Pharmaceutical Education·Christine M FormeaJoanna L Stollings
May 24, 2013·Clinical Pharmacology and Therapeutics·S A ScottUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Nov 21, 2013·The New England Journal of Medicine·Stephen E KimmelUNKNOWN COAG Investigators
Nov 21, 2013·The New England Journal of Medicine·Munir PirmohamedUNKNOWN EU-PACT Group
Sep 16, 2014·Pharmacotherapy·Aniwaa Owusu-ObengJulie A Johnson
Nov 18, 2014·Clinical Pharmacology and Therapeutics·M J Ratain, J A Johnson
Nov 18, 2014·Clinical Pharmacology and Therapeutics·A C J W Janssens, P A Deverka
Nov 18, 2014·Clinical Pharmacology and Therapeutics·N K Gillis, F Innocenti
Jan 7, 2015·Circulation. Cardiovascular Genetics·Kiran MusunuruUNKNOWN American Heart Association Council on Functional Genomics and Translational Biology,Council on Clinical Cardiology, Council
Jan 7, 2015·Journal of Personalized Medicine·Casey Lynnette OverbyOmri Gottesman
Mar 17, 2015·Lancet Neurology·Adrian Burton
Jan 1, 2014·Personalized Medicine·Sridharan Raghavan, Jason L Vassy

❮ Previous
Next ❯

Citations

May 20, 2020·Pharmacogenomics·Youssef M RomanPatricia W Slattum
Oct 21, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Divya TalwarLei-Shih Chen
Jul 27, 2017·Pharmacogenomics·Daniel L HertzVicki L Ellingrod
Jun 1, 2019·Journal of the American College of Clinical Pharmacy : JAACP·J Kevin HicksJames C Lee
Jan 17, 2017·Clinical Pharmacology and Therapeutics·J A LuzumUNKNOWN Pharmacogenomics Research Network Translational Pharmacogenetics Program
Jul 28, 2020·Journal of Clinical Medicine·Meghan J ArwoodJohn G Gums
Jun 11, 2020·Healthcare·John StegelmeierJared Barrott
Oct 8, 2021·Translational Psychiatry·Catherine R VirelliJames L Kennedy

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

La Revue du praticien
Jean-Michel Chabot
Academic Medicine : Journal of the Association of American Medical Colleges
A Stagnaro-Green
The American Journal of the Medical Sciences
Jeffrey G Wong
The New England Journal of Medicine
Asit B Shil, Maureen P Strohm
© 2022 Meta ULC. All rights reserved